Stay Updated
Press Releases
STATEMENT: P4AD Warns Proposed Tariffs On Generic Drugs Would Raise Prices For Patients
WASHINGTON, D.C. — Last night, President Trump announced his plans to instate a 100% tariff on generic drugs beginning in August 2028, with a planned increase up to 200% in 2029, one year after his term ends. According to the president’s Truth Social announcement, the change will not impact brand-name drugs. In response, P4AD CEO […]
Press Releases
WASHINGTON, D.C. — Today, the U.S. Supreme Court unanimously ruled in favor of Hikma in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., preserving a critical pathway that allows lower-cost generic drugs to come to market. The case focused on “skinny labeling,” a long-standing process that allows generic manufacturers to seek approval for off-patent uses of medicines while still […]
Press Releases
WASHINGTON, D.C. — Following the Supreme Court’s decision this morning to decline petitions from AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim challenging the Medicare Drug Price Negotiation Program, Patients For Affordable Drugs and Public Citizen held a press briefing with a patient advocate and legal expert to discuss the implications for patients and the […]
Press Releases
The 2022 Prescription Drug Law Is Delivering Lasting Reductions in Prescription Drug Costs
WASHINGTON, D.C. — As debate continues around new proposals to lower prescription drug prices for Americans, one thing is clear: the 2022 prescription drug law is already helping to lower costs for millions of patients across the country. “The facts speak for themselves,” said Merith Basey, CEO of Patients For Affordable Drugs. “The Medicare drug price reforms are […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs has reached a major milestone: more than 40,000 vetted patient stories are now on our interactive map, documenting the real-world harm caused by high drug prices. There are stories from every state and every congressional district in the country and the map allows users to explore stories by disease, ZIP code, and more, offering […]
Press Releases
P4AD Responds to Regeneron MFN Deal and Gene Therapy Approval
WASHINGTON, D.C. — Regeneron is the latest drugmaker to reach a most-favored-nation (MFN) pricing agreement with the Trump administration, part of a broader set of voluntary deals aimed at bringing U.S. drug prices in line with those in other high-income countries. The company was the last of the 17 corporations that received letters in July […]
Press Releases
Patients For Affordable Drugs Responds to Trump’s Announcement On Tariffs
WASHINGTON, DC – Following President Trump’s announcement of sweeping tariffs of up to 100% on imported brand-name prescription drugs and their ingredients, Patients For Affordable Drugs CEO Merith Basey released the following statement: “While these tariffs aim to pressure pharmaceutical corporations into U.S. manufacturing and Most Favored Nation agreements, the current MFN deals remain opaque and voluntary, and have […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs today announced the addition of new leaders to its board of directors, further strengthening the organization’s expertise and continued growth. “Our new board members bring a depth of knowledge across medicine, law, public health, and business, along with patient experience — exactly the expertise this fight demands,” said Merith Basey, CEO […]